Myocarditis Historical Perspective: Difference between revisions

Jump to navigation Jump to search
Line 14: Line 14:


*The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
*The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
*In 2020, Homa  was the first to discover the association between myocarditis and the development of cardiomyopathy.
**In 2020, Homa  was the first to discover the association between myocarditis and the development of cardiomyopathy.
*In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
*In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].



Revision as of 14:58, 8 May 2020

Myocarditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Adrenergic Myocarditis
Giant Cell Myocarditis

Causes

Differentiating Myocarditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myocarditis Historical Perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Myocarditis Historical Perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myocarditis Historical Perspective

CDC on Myocarditis Historical Perspective

Myocarditis Historical Perspective in the news

Blogs on Myocarditis Historical Perspective

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Myocarditis Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2] Homa Najafi, M.D.[3]


Overview

Historical Perspective

Discovery

  • There is limited information about the historical perspective of [disease name].

OR

  • Myocarditis was first discovered by Dr Najafi , from Iran , in 2020.
  • The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
    • In 2020, Homa was the first to discover the association between myocarditis and the development of cardiomyopathy.
  • In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].

Landmark Events in the Development of Treatment Strategies

Impact on Cultural History

Famous Cases

The following are a few famous cases of [disease name]:

References

Template:WH Template:WS


References


Template:WS Template:WH